Arrowhead Pharmaceuticals (ARWR) Amortizatization of Intangibles: 2011-2025
Historic Amortizatization of Intangibles for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Sep 2025 value amounting to $1.2 million.
- Arrowhead Pharmaceuticals' Amortizatization of Intangibles fell 88.82% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 78.45%. This contributed to the annual value of $5.8 million for FY2025, which is 78.45% up from last year.
- As of Q3 2025, Arrowhead Pharmaceuticals' Amortizatization of Intangibles stood at $1.2 million, which was down 29.20% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Arrowhead Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $11.1 million in Q3 2024 and a low of -$7.0 million during Q2 2024.
- For the 3-year period, Arrowhead Pharmaceuticals' Amortizatization of Intangibles averaged around $1.1 million, with its median value being $948,000 (2023).
- Per our database at Business Quant, Arrowhead Pharmaceuticals' Amortizatization of Intangibles slumped by 3,401.96% in 2022 and then skyrocketed by 1,027.66% in 2024.
- Quarterly analysis of 5 years shows Arrowhead Pharmaceuticals' Amortizatization of Intangibles stood at $280,000 in 2021, then plummeted by 346.43% to -$690,000 in 2022, then surged by 221.01% to $835,000 in 2023, then spiked by 583.11% to $5.7 million in 2024, then plummeted by 88.82% to $1.2 million in 2025.
- Its Amortizatization of Intangibles stands at $1.2 million for Q3 2025, versus $1.8 million for Q2 2025 and -$2.9 million for Q1 2025.